ARCTArcturus Therapeutics Holdings Inc.
$6.82-49% 1Y
$6.82
$5.5252 weeks$23.16
Is the price fair?
What ARCT's price assumes
Arcturus Therapeutics Holdings Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 5.18× revenue.
5.18
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 1.15
Price / book · as of 2026-Q1
- EV / sales
- 0.76
EV / sales
Details›
- Price / bookas of 2026-Q1
- 1.15
- EV / EBIToperating margin −348%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 0.76
- Market capitalisation
- $365M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.